Related Experiment Videos
Surveillance and vaccination coverage of measles and rubella in Northern Italy
Antonella Amendola1, Laura Bubba, Antonio Piralla
1a Department of Biomedical Sciences for Health; University of Milan; Milan, Italy.
Abstract:
Measles and rubella are infectious diseases and humans are the only reservoir of these infections. Effective vaccines are available with the potential for measles (MV) and rubella (RuV) virus eradication. According to the World Health Organisation guidelines, a national plan was approved in Italy in 2013 to achieve the MV/RuV elimination by 2015, and active MV/RuV integrated surveillance initiated. Towards this purpose, a regional laboratory centre was set up on 1 September 2013 in Lombardy, Northern Italy. This paper aimed at: (1) evaluating measles-mumps-rubella (MMR) vaccine coverage and MV/RuV notified cases retrospectively; and (2) presenting the results of MV/RuV integrated surveillance (laboratory confirmed and viral genetic profiles). The 95% target for MMR vaccine coverage was achieved in 2001, and coverage increased until 2007 (96.6%), but then a decreasing trend was observed. Since 2000 to 2014, 3026 rubella cases were notified, with nearly 58% of them in the 2002 epidemic. From 2009, less than 45 RuV cases per year were reported. From 2000 to 2014, 5024 measles cases were notified. Since 2008, three large outbreaks (in 2008, 2011, and 2013) were observed. From data obtained during our surveillance activity, there were no rubella cases, and 57.5% (46/80) collected samples were MV-positive by real-time RT-PCR. A fragment of the MV N gene was sequenced from 37 MV-positive samples; D8, D9, and B3 genotypes were detected. Data obtained retrospectively and from active surveillance underline the necessity to achieve and maintain high vaccination coverage and to improve surveillance and the effectiveness of healthcare actions.
Insights
High measles-mumps-rubella (MMR) vaccination coverage is crucial for eliminating measles and rubella viruses. Surveillance data show a decline in coverage and ongoing measles circulation, highlighting the need for improved vaccination strategies.
Area of Science:
- Public Health
- Virology
- Epidemiology
Background:
- Measles (MV) and rubella (RuV) are vaccine-preventable infectious diseases with humans as the sole reservoir.
- Effective measles-mumps-rubella (MMR) vaccines offer the potential for global eradication of MV and RuV.
- Italy implemented a national plan in 2013 to achieve MV/RuV elimination by 2015, supported by integrated surveillance.
Purpose of the Study:
- To retrospectively evaluate MMR vaccine coverage and notified MV/RuV cases in Lombardy, Italy.
- To present findings from active MV/RuV integrated surveillance, including laboratory confirmation and viral genetic profiling.
- To assess the effectiveness of public health interventions aimed at MV/RuV elimination.
Main Methods:
- Retrospective analysis of MMR vaccine coverage data from 2000 to 2014.
- Review of notified measles and rubella cases during the same period.
- Prospective integrated surveillance for MV/RuV, including real-time RT-PCR and genetic sequencing of positive samples.
Main Results:
- MMR vaccine coverage in Lombardy reached the 95% target in 2001, peaking at 96.6% in 2007, followed by a declining trend.
- Significant numbers of rubella cases (3026) and measles cases (5024) were notified between 2000 and 2014, with notable outbreaks.
- Integrated surveillance detected no rubella cases but confirmed measles in 57.5% of tested samples, with genotypes D8, D9, and B3 identified.
Conclusions:
- Maintaining high vaccination coverage is essential for measles and rubella elimination.
- The declining vaccination trends and persistent measles circulation underscore the need for enhanced surveillance and public health interventions.
- Effective healthcare strategies are critical to prevent resurgence and achieve the goal of MV/RuV eradication.
Related Concept Videos
Vaccinations
Principles of Disease Surveillance
Investigation of Disease Outbreaks
Vaccines
Infectious Diseases and Their Occurrence
Steps in Outbreak Investigation